Fetal neural grafts for Huntington's disease: A prospective view

Movement Disorders

Volumn 17, Issue 3, 2002, Pages 439-444

  Bachooud Lévi, Anne Catherine ^a,b   Hantraye, Philippe ^c   Peschanski, Marc ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c DIF   (France)

Author keywords

Cell therapy; Clinical trial; Neurodegenerative disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A;

CLINICAL PROTOCOL; DISSECTION; EDITORIAL; FETAL TISSUE TRANSPLANTATION; FOLLOW UP; HUMAN; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL PARAMETERS; NERVE GRAFT; NEUROBLAST; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRIATE CORTEX; SURGICAL TECHNIQUE;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CLINICAL TRIALS; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE; PREGNANCY; TREATMENT OUTCOME;

EID: 0036589961     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10117     Document Type: Editorial

References (22)

1. Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boisse MF, Grandmougin T, Jeny R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 2000; 356:1975-1979.
2. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 2000;97:13877-13882.
3. Lindvall O, Björklund A. First step towards cell therapy for Huntington's disease. Lancet 2000;356:1945-1946.
4. Bachoud-Levi AC, Maison P, Bartolomeo P, Boisse MF, Dalla Barba G, Ergis AM, Baudic S, Degos JD, Cesaro P, Peschanski M. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001;56:1052-1058.
5. Pakzaban P, Deacon TW, Burns LH, Isacson O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp Brain Res 1993;97:13-22.
6. Palfi S, Nguyen JP, Brugieres P, Le Guerinel C, Hantraye P, Remy P, Rostaing S, Defer GL, Cesaro P, Keravel Y, Peschanski M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp Neurol 1998;150:272-281.
7. Peschanski M, Defer G, N'Guyen JP, Ricolfi F, Monfort JC, Remy P, Geny C, Samson Y, Hantraye P, Jeny R, Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994;117:487-499.
8. Bachoud-Levi A, Bourdet C, Brugieres P, Nguyen JP, Grandmougin T, Haddad B, Jeny R, Bartolomeo P, Boisse MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Remy P, Palfi S, Defer GL, Cesaro P, Hantraye P, Peschanski M. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 2000;161: 194-202.
9. Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Bjorklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 1986; 65:235-240.
10. Belkadi AM, Geny C, Naimi S, Jeny R, Peschanski M, Riche D. Maturation of fetal human neural xenografts in the adult rat brain. Exp Neurol 1997;144:369-380.
11. Geny C, Naimi-Sadaoui S, Jeny R, Belkadi AM, Juliano SL, Peschanski M. Long-term delayed vascularization of human neural transplants to the rat brain. J Neurosci 1994;14:7553-7562.
12. Nakao N, Grasbon-Frodl EM, Widner H, Brundin P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 1996;74:959-970.
13. Pearlman SH, Levivier M, Collier TJ, Sladek JR Jr, Gash DM. Striatal implants protect the host striatum against quinolinic acid toxicity. Exp Brain Res 1991;84:303-310.
14. Levivier M, Gash DM, Przedborski S. Time course of the neuro-protective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience 1995;69:43-50.
15. Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK, Pettengill FK, Bird ED. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991;48:800-804.
16. Juliano SL, Dusart I, Peschanski M. Somatic activation of thalamic neurons transplanted into lesioned somatosensory thalamus. Brain Res 1989;478:356-360.
17. Isacson O, Dunnett SB, Bjorklund A. Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc Natl Acad Sci U S A 1986;83:2728-2732.
18. Peschanski M, Isacson O. Fetal homotypic transplant in the excitotoxically neuron-depleted thalamus: light microscopy. J Comp Neurol 1988;274:449-463.
19. Wictorin K, Isacson O, Fischer W, Nothias F, Peschanski M, Bjorklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum. I. Subcortical afferents. Neuroscience 1988;27:547-562.
20. Marty S, Peschanski M. Effects of target deprivation on the morphology and survival of adult dorsal column nuclei neurons. J Comp Neurol 1995;356:523-536.
21. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Gofftedo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E. Loss of Huntington-mediated BDNF gene transcription in Huntington's disease. Science 2001;293:493-498.
22. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995;68:273-285.